CC-90001 was nominated by reviewer Christian Kuttruff. CC-90001 is a JNK (c-Jun N-Terminal Kinase) inhibitor and a Phase II clinical candidate for idiopathic pulmonary fibrosis (NCT03142191). Christian says, “Preclinical…
CC-90001 was nominated by reviewer Christian Kuttruff. CC-90001 is a JNK (c-Jun N-Terminal Kinase) inhibitor and a Phase II clinical candidate for idiopathic pulmonary fibrosis (NCT03142191). Christian says, “Preclinical…